Patents by Inventor Carol K. Wada

Carol K. Wada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090263407
    Abstract: Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.
    Type: Application
    Filed: April 16, 2009
    Publication date: October 22, 2009
    Applicant: ABBOTT LABORATORIES
    Inventors: Prasad A. Dande, Todd M. Hansen, Robert D. Hubbard, Carol K. Wada, Lu Tian, Xiaobin Zhao
  • Patent number: 7468371
    Abstract: Compounds of the present invention are useful for inhibiting protein tyrosine kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    Type: Grant
    Filed: March 24, 2005
    Date of Patent: December 23, 2008
    Assignee: Abbott Laboratories Inc.
    Inventors: Lee D. Arnold, Jürgen Dinges, Richard W. Dixon, Stevan W. Djuric, Anna M. Ericsson, Kimba Fischer, Alan F. Gasiecki, Vijaya J. Gracias, James H. Holms, Makoto Takeshita, Michael R. Michaelides, Melanie A. Muckey, Paul Rafferty, Douglas H. Steinman, Carol K. Wada, Zhiren Xia, Irini Akritopoulou-Zanze, Henry Q. Zhang
  • Patent number: 7202363
    Abstract: Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    Type: Grant
    Filed: July 26, 2004
    Date of Patent: April 10, 2007
    Assignee: Abbott Laboratories
    Inventors: Patrick Betschmann, Andrew F. Burchat, David J. Calderwood, Michael L. Curtin, Steven K. Davidsen, Heather M. Davis, Robin R. Frey, Howard R. Heyman, Gavin C. Hirst, Peter Hrnciar, Michael R. Michaelides, Melanie A. Muckey, Kelly D. Mullen, Paul Rafferty, Carol K. Wada
  • Publication number: 20030225098
    Abstract: The present application is directed to pyrazolopyrirnidine and furopyrimidine analogs of the formula (I) 1
    Type: Application
    Filed: March 21, 2003
    Publication date: December 4, 2003
    Inventors: Gavin C. Hirst, Lee D. Arnold, Andrew Burchat, Neil Wishart, David Calderwood, Carol K. Wada, Michael R. Michaelides, Zhiqin Ji, Melanie Muckey
  • Publication number: 20030199525
    Abstract: The present application is directed to pyrazolopyrimidine and furopyrimnidine analogs of the formula (I) 1
    Type: Application
    Filed: March 21, 2002
    Publication date: October 23, 2003
    Inventors: Gavin C. Hirst, Lee D. Arnold, Andrew Burchat, Neil Wishart, Carol K. Wada, Michael R. Michaelides, Zhiqin Ji, Melanie Muckey
  • Publication number: 20020177594
    Abstract: Compounds having the formula 1
    Type: Application
    Filed: October 26, 2001
    Publication date: November 28, 2002
    Inventors: Michael L. Curtin, Yujia Dai, Steven K Davidsen, Robin R. Frey, Yan Guo, Howard R. Heyman, James H. Holms, Zhiqin Ji, Michael R. Michaelides, Anil Vasudevan, Carol K. Wada
  • Publication number: 20020103192
    Abstract: Substituted trifluoromethyl ketones, ketooxazoles, ketoamides, ketoesters, and diketones having the formula 1
    Type: Application
    Filed: March 14, 2001
    Publication date: August 1, 2002
    Inventors: Michael L. Curtin, Steven K. Davidsen, Robin R. Frey, Howard R. Heyman, Michael R. Michaelides, Anil Vasudevan, Carol K. Wada
  • Publication number: 20020007060
    Abstract: Compounds having the formula 1
    Type: Application
    Filed: July 16, 2001
    Publication date: January 17, 2002
    Inventors: Steven K. Davidsen, Michael L. Curtin, Joseph F. Dellaria, Alan S. Florjancic, Jamie Giesler-Stacy, Jianchung Gong, Yan Guo, H. Robin Heyman, James H. Holms, Michael R. Michaelides, Douglas Steinman, Carol K. Wada, Lianhong Xu
  • Patent number: 6294573
    Abstract: Compounds having the formula are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: September 25, 2001
    Assignee: Abbott Laboratories
    Inventors: Michael L. Curtin, Yujia Dai, Steven K. Davidsen, Joseph F. Dellaria, Jr., Alan S. Florjancic, Jianchun Gong, Yan Guo, Howard R. Heyman, James H. Holms, Michael R. Michaelides, Jamie R. Stacey, Douglas H. Steinman, Carol K. Wada, Lianhong Xu
  • Patent number: 6235786
    Abstract: Compounds having the formula are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: May 22, 2001
    Assignee: Abbott Laboratories
    Inventors: Yujia Dai, Steven K. Davidsen, Michael R. Michaelides, Jamie R. Stacey, Douglas H. Steinman, Carol K. Wada
  • Patent number: 5985911
    Abstract: C-terminal compounds of formula ##STR1## are potent inhibitors of matrix metalloproteinase and are useful in the treatment of diseases in which matrix metalloproteinase play a role. Also disclosed are matrix metalloproteinase inhibiting compositions and a method of inhibiting matrix metalloproteinase in a mammal.
    Type: Grant
    Filed: December 17, 1997
    Date of Patent: November 16, 1999
    Assignee: Abbott Laboratories
    Inventors: Steven K. Davidsen, Alan S. Florjancic, George S. Sheppard, Jamie R. Giesler, Lianhong Xu, Yan Guo, Michael L. Curtin, Michael R. Michaelides, Carol K. Wada, James H. Holms